Lumiata's Risk Matrix is designed to offer predictions for 20 chronic condition patient populations, such as diabetes, chronic kidney disease and congestive heart failure.
Intel Capital led the round, with participation from existing investors including Blue Cross Blue Shield Venture Partners, Sandbox Industries, and Khosla Ventures.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Lumiata, a Bay Area predictive health analytics startup founded in 2013, is looking to raise $6.3 million, according to an SEC filing. The raise from securities comes less than a year after Lumiata, based in San Mateo, raised $4 million in venture capital. So far, it has raised $5 million, with another $1.3 million remaining, […]
Google has been fine tuning its search engine to produce better, more targeted search results in what it refers to as a Knowledge Graph. Facebook has synthesized its users data to illustrate shared interests in social graphs. One company is applying those big data graph concepts to healthcare. Healthcare IT startup Lumiata, formerly known as […]